Matches in SemOpenAlex for { <https://semopenalex.org/work/W4377011129> ?p ?o ?g. }
- W4377011129 endingPage "108546" @default.
- W4377011129 startingPage "108546" @default.
- W4377011129 abstract "Drug resistance in malaria parasites necessitates the development of new antimalarial drugs with unique mechanisms of action. In the present research work, the PABA conjugated 1,3,5-triazine derivatives were designed as an antimalarial agent.In this present work, a library of two hundred-seven compounds was prepared in twelve different series such as [4A (1-23), 4B(1-22), 4C(1-21), 4D(1-20), 4E(1-19), 4F(1-18), 4G(1-17), 4H(1-16), 4I(1-15), 4J(1-13), 4K(1-12) and 4L(1-11) ] respectively using different primary and secondary aliphatic and aromatic amines. Ten compounds were ultimately selected through in silico screening. They were synthesized by conventional and microwave-assisted methods followed by in vitro antimalarial evaluations performed in chloroquine-sensitive (3D7) and resistant (DD2) strains of P. falciparum.The docking results showed that compound 4C(11) had good binding interaction with Phe116, Met55 (-464.70 kcal/mol) and Phe116, Ser111 (-432.60 kcal/mol) against wild (1J3I) and quadruple mutant (1J3K) type of Pf-DHFR. Furthermore, in vitro, antimalarial activity results indicated that compound 4C(11) showed potent antimalarial activity against chloroquine-sensitive (3D7) and chloroquine-resistant (Dd2) strain of P. falciparum along with IC50 (14.90 μg mL-1) and (8.30 μg mL-1).These PABA-substituted 1,3,5-triazine compounds could be exploited to develop a new class of Pf-DHFR inhibitors as a lead candidate." @default.
- W4377011129 created "2023-05-19" @default.
- W4377011129 creator A5007613008 @default.
- W4377011129 creator A5026894755 @default.
- W4377011129 creator A5041751854 @default.
- W4377011129 creator A5046413711 @default.
- W4377011129 creator A5067487973 @default.
- W4377011129 creator A5068730923 @default.
- W4377011129 creator A5074784265 @default.
- W4377011129 creator A5083584884 @default.
- W4377011129 date "2023-07-01" @default.
- W4377011129 modified "2023-09-26" @default.
- W4377011129 title "In silico screening, synthesis, and antimalarial evaluation of PABA substituted 1,3,5-triazine derivatives as Pf-DHFR inhibitors" @default.
- W4377011129 cites W1184700944 @default.
- W4377011129 cites W1973786968 @default.
- W4377011129 cites W1979040389 @default.
- W4377011129 cites W1990074634 @default.
- W4377011129 cites W1990357087 @default.
- W4377011129 cites W2019920189 @default.
- W4377011129 cites W2033963939 @default.
- W4377011129 cites W2038522569 @default.
- W4377011129 cites W2044538318 @default.
- W4377011129 cites W2051072666 @default.
- W4377011129 cites W2054234416 @default.
- W4377011129 cites W2057089852 @default.
- W4377011129 cites W2075264893 @default.
- W4377011129 cites W2088364713 @default.
- W4377011129 cites W2098124996 @default.
- W4377011129 cites W2104931530 @default.
- W4377011129 cites W2111066057 @default.
- W4377011129 cites W2162657387 @default.
- W4377011129 cites W2179687049 @default.
- W4377011129 cites W2782539068 @default.
- W4377011129 cites W2794207130 @default.
- W4377011129 cites W2936015784 @default.
- W4377011129 cites W2953181125 @default.
- W4377011129 cites W3099492178 @default.
- W4377011129 cites W3136533107 @default.
- W4377011129 doi "https://doi.org/10.1016/j.exppara.2023.108546" @default.
- W4377011129 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37196703" @default.
- W4377011129 hasPublicationYear "2023" @default.
- W4377011129 type Work @default.
- W4377011129 citedByCount "0" @default.
- W4377011129 crossrefType "journal-article" @default.
- W4377011129 hasAuthorship W4377011129A5007613008 @default.
- W4377011129 hasAuthorship W4377011129A5026894755 @default.
- W4377011129 hasAuthorship W4377011129A5041751854 @default.
- W4377011129 hasAuthorship W4377011129A5046413711 @default.
- W4377011129 hasAuthorship W4377011129A5067487973 @default.
- W4377011129 hasAuthorship W4377011129A5068730923 @default.
- W4377011129 hasAuthorship W4377011129A5074784265 @default.
- W4377011129 hasAuthorship W4377011129A5083584884 @default.
- W4377011129 hasConcept C104317684 @default.
- W4377011129 hasConcept C159110408 @default.
- W4377011129 hasConcept C178790620 @default.
- W4377011129 hasConcept C185592680 @default.
- W4377011129 hasConcept C202751555 @default.
- W4377011129 hasConcept C203014093 @default.
- W4377011129 hasConcept C21951064 @default.
- W4377011129 hasConcept C2775905019 @default.
- W4377011129 hasConcept C2776303721 @default.
- W4377011129 hasConcept C2777425658 @default.
- W4377011129 hasConcept C2777752497 @default.
- W4377011129 hasConcept C2778048844 @default.
- W4377011129 hasConcept C2778218704 @default.
- W4377011129 hasConcept C2778371730 @default.
- W4377011129 hasConcept C2908859342 @default.
- W4377011129 hasConcept C41685203 @default.
- W4377011129 hasConcept C55493867 @default.
- W4377011129 hasConcept C71240020 @default.
- W4377011129 hasConcept C71924100 @default.
- W4377011129 hasConcept C86803240 @default.
- W4377011129 hasConcept C98274493 @default.
- W4377011129 hasConceptScore W4377011129C104317684 @default.
- W4377011129 hasConceptScore W4377011129C159110408 @default.
- W4377011129 hasConceptScore W4377011129C178790620 @default.
- W4377011129 hasConceptScore W4377011129C185592680 @default.
- W4377011129 hasConceptScore W4377011129C202751555 @default.
- W4377011129 hasConceptScore W4377011129C203014093 @default.
- W4377011129 hasConceptScore W4377011129C21951064 @default.
- W4377011129 hasConceptScore W4377011129C2775905019 @default.
- W4377011129 hasConceptScore W4377011129C2776303721 @default.
- W4377011129 hasConceptScore W4377011129C2777425658 @default.
- W4377011129 hasConceptScore W4377011129C2777752497 @default.
- W4377011129 hasConceptScore W4377011129C2778048844 @default.
- W4377011129 hasConceptScore W4377011129C2778218704 @default.
- W4377011129 hasConceptScore W4377011129C2778371730 @default.
- W4377011129 hasConceptScore W4377011129C2908859342 @default.
- W4377011129 hasConceptScore W4377011129C41685203 @default.
- W4377011129 hasConceptScore W4377011129C55493867 @default.
- W4377011129 hasConceptScore W4377011129C71240020 @default.
- W4377011129 hasConceptScore W4377011129C71924100 @default.
- W4377011129 hasConceptScore W4377011129C86803240 @default.
- W4377011129 hasConceptScore W4377011129C98274493 @default.
- W4377011129 hasFunder F4320320719 @default.
- W4377011129 hasLocation W43770111291 @default.
- W4377011129 hasLocation W43770111292 @default.
- W4377011129 hasOpenAccess W4377011129 @default.